logo

For the Inventor, By the Inventor

Lanark, United Kingdom

Robert T Logan

USPTO Granted Patents = 10

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Lanark, GB (1981 - 1994)
  • Lanarkshire, GB (1993 - 1995)

Company Filing History:

goldMedal10 out of 776 
 
Akzo N.v.
 patents

Years Active: 1981-1995

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5462959 - 4-aryl-imidazole derivatives (1995-10-31),
2. 5276052 - Use of a benzo[b]thiopene-2-carboximidamide derivative (1994-01-04),
3. 5254575 - 4-aryl-thiazole derivatives (1993-10-19),
4. 5192755 - Pregnane derivatives as immunomodulators (1993-03-09),
5. 5026724 - Compounds with bronchodilator activity (1991-06-25),
6. 4952571 - Pyridazinone derivatives (1990-08-28),
7. 4929636 - Positive inotrophic benzothiazole and benzothiophene compositions and (1990-05-29),
8. 4705782 - Indene and naphthalene derivatives (1987-11-10),
9. 4665206 - Benzothiophene derivatives (1987-05-12),
10. 4260605 - Novel alkylated pregnanes, processes for their preparation and (1981-04-07),

Title: Unveiling the Inventive Journey of Robert T Logan

Introduction:

Robert T Logan, a talented innovator hailing from Lanark, GB, has made significant contributions to the field of pharmaceuticals through his inventive spirit and dedication. With an impressive portfolio of 10 patents under his belt, Logan continues to push the boundaries of scientific exploration and discovery.

Latest Patents:

Among his latest patents, Logan has introduced groundbreaking inventions such as the 4-aryl-imidazole derivatives. This novel compound has shown promise in various applications, highlighting Logan's prowess in developing innovative solutions. Additionally, his work on the utilization of benzo[b]thiopene-2-carboximidamide derivatives for the treatment of heart failure underscores his commitment to improving healthcare outcomes.

Career Highlights:

Currently affiliated with Akzo N.V., a renowned pharmaceutical company, Logan thrives in an environment that fosters innovation and collaboration. His tenure at Akzo N.V. has been marked by a series of achievements, showcasing his ability to translate visionary ideas into tangible products that benefit society at large.

Collaborations:

In his pursuit of excellence, Logan has had the privilege of working alongside esteemed colleagues such as Robert G Roy and James Redpath. These collaborative efforts have not only enriched Logan's creative process but have also led to the development of cutting-edge solutions that hold the potential to revolutionize the pharmaceutical industry.

Conclusion:

In conclusion, Robert T Logan's inventive journey serves as a testament to his ingenuity and passion for driving positive change through innovation. His relentless pursuit of scientific excellence and his unwavering commitment to improving healthcare underscore Logan's status as a trailblazer in the field of pharmaceutical research. As he continues to explore new frontiers and push the boundaries of what is possible, Logan's legacy is destined to inspire future generations of inventors and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…